Evaluation of N-hydroxymethylphthalimide in alkaline medium: Novel entry to the tricyclic [1,3]oxazepine core via an intramolecular π and O-cationic cyclization

Journal of Heterocyclic Chemistry

Volumn 40, Issue 3, 2003, Pages 499-505

  Cul, Armelle ^a   Chihab Eddine, Abderrahim ^b   Pesquet, Anthony ^a   Marchalín, Štefan ^c   Daïch, Adam ^a  

^a UNIVERSITÉ DU HAVRE   (France)

^b FACULTÉ DES SCIENCES   (Morocco)

^c SLOVAK UNIVERSITY OF TECHNOLOGY   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

N HYDROXYMETHYLPHTHALIMIDE; OXAZEPINE DERIVATIVE; PHTHALIMIDE DERIVATIVE; UNCLASSIFIED DRUG;

ALKALINITY; ALKYLATION; ARTICLE; ARYLATION; CYCLIZATION; ISOMERISM; REACTION ANALYSIS; SYNTHESIS;

EID: 0037961033     PISSN: 0022152X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jhet.5570400314     Document Type: Article

References (44)

1. [a] A. Wolpert, L. White, L. Dana, A. A. Sugerman, A. D. Arengo, G. M. Simpson, M. P. Bishop and D. M.; Gallant, J. Clin. Pharmacol., 10, 175 (1970);
2. [b] J. Schmutz, Arzneim. Forsch., 25, 712 (1975).
3. E. N. Greenblatt, A. S. Lippa and A. C. Osterberg, Arch. Int. Pharmacodyn., 233, 107 (1987).
4. G. L. Sathananthan, R. Matz, H. Thompson and S. Gershon, Curr. Ther. Res., 15, 919 (1973).
5. It has been reported also, by same authors, that Amoxapine appears to be devoid of anticholinergic or anticonvulsant activity. See: E. Greenblatt and A. C. Osterberg, Fed. Proc., 27, 438 (1968).
6. Y. Liao, B. J. Venhuis, N. Rodenhuis, W. Timmerman, H. Wikström, E. Meier, G. D. Bartoszyk, H. Böttcher, C. A. Seyfried and S. Sundell, J. Med. Chem., 42, 2235 (1999).
7. K. Nagarajan, J. Indian Chem. Soc., 74, 831 (1997).
8. A. R. Katritzky, Y-J. Xu, H-Y. He and S. Mehta, J. Org. Chem., 66, 5590 (2001) and the references cited therein.
9. G. A. Kraus and S. Yue, J. Org. Chem., 48, 2936 (1983).
10. [a] N. Yamazaki, H. Suzuki and C. Kibayashi, J. Org. Chem., 62, 8280 (1997);
11. [b] N. Yamazaki, T. Ito and C. Kibayashi, Synlett, 37 (1999;
12. [c] T. Ito, N. Yamazaki and C. Kibayashi, Synlett, 1506 (2001).
13. R. Grigg, I. Köppen, M. Rasparini and V. Sridharan, J. Chem. Soc., Chem. Commun., 964 (2001).
14. Only one example of substituted pyrrolidino[1,3]oxazepine was obtained as a minor product (9.5% yield), see: J. Griffiths and J. A. Murphy, Tetrahedron, 48, 5543 (1992).
15. [a] A. Mamouni, A. Daïch, Š. Marchalín and B. Decroix, Heterocycles, 54, 275 (2001);
16. [b] X. Zhang, W. Jiang and A. C. Schmitt, Tetrahedron Lett., 42, 4943 (2001);
17. [c] P. Pigeon, A. Mamouni, J. Sikoraiová, Š. Marchalín and B. Decroix, Tetrahedron, 57, 4939 (2001);
18. [d] J. Sikoraiová, S. Marchalín, A. Daïch and B. Decroix, Tetrahedron Lett., 43, 4747 (2002).
19. [a] N. Hucher, A. Daïch and B. Decroix, Org. Lett., 2, 1201 (2000);
20. [b] N. Hucher, B. Decroix and A. Daïch, J. Org. Chem., 66, 4695 (2001);
21. A. Chihab-Eddine, A. Daïch, A. Jilale and B. Decroix, Tetrahedron Lett., 42, 573 (2001).
22. N. Hucher, A. Daïch and B. Decroix, J. Heterocyclic Chem., 35, 1477 (1998).
23. [a] H. E. Zaugg, Synthesis, 49 (1970);
24. [b] H. E. Zaugg, Synthesis, 85 (1984);
25. [c] H. E. Zaugg, Synthesis, 181 (1984);
26. [d] The same N-acyliminium ion B was also generated from N-chloromethylphthalimide (7) in the presence of Brönsted or Lewis acid. For this end, see for example:
27. [e] I. Iley, T. Calheiros and R. Moreira, Bioorg. Med. Chem. Lett., 8, 955 (1998), and
28. [f] B. Venugopalan, P. J. Karnik and S. Shinde, J. Chem. Soc., Perkin Trans. 1, 1015 (1996), respectively.
29. In this area, see for example: J. D. Coyle and G. L. Newport, J. Chem. Soc., Perkin Trans. 1, 93 (1980).
30. S-D. Cho, H-J. Kim, C. Ahn, J. R. Falck and D-S. Shin, Tetrahedron Lett., 40, 3215 (1999).
31. P. Pigeon and B. Decroix, J. Heterocyclic Chem., 33, 129 (1996).
32. M. A. Pasquini, R. Le Goaller and J. L. Pierre, Tetrahedron, 36, 1223 (1980).
33. A. K. Rose, F. Greer and C. C. Price, J. Org. Chem., 23, 1335 (1958).
34. A. Daïch, Š. Marchalín, P. Pigeon and B. Decroix, Tetrahedron Lett., 39, 9187 (1998).
35. M. Wada, H. Nakai, K. Aoe, K. Kotera, Y. Sato, Y. Hatanaka and Y. Kanaoka, Tetrahedron, 39, 1273 (1983).
36. This product was prepared by heating at 90 °C in DMF N-bromomethylphthalimide and benzyl alcohol in near neutral conditions (92% yield); see: Y. Sato, H. Nakai, M. Wada, H. Ogiwara, T. Mizoguchi, Y. Migita, Y. Hatanaka and Y. Kanaoka, Chem. Pharm. Bull., 30, 1639 (1982).
37. 2/hexane (4:1) as eluent and its yield did not exceed 8% whatever the reaction conditions.
38. When the reaction was performed at -40 to -35°, the reaction times increase to 2.5-3 days.
39. [a] A. Mamouni, A. Daïch and B. Decroix, J. Heterocyclic Chem., 33, 1251 (1996);
40. [b] J. Sikoraiová, A. Chihab-Eddine, Š. Marchalín and A. Daïch, J. Heterocyclic Chem., 39, 383 (2002).
41. Acids other than PTSA and TFA provokes rapidly, in all cases, the decomposition of the starting α-hydroxylactams 11a,b.
42. A. Chihab-Eddine, A. Daïch, A. Jilale and B. Decroix, J. Heterocyclic Chem., 37, 1543 (2000).
43. Diacetal products 12a and 12b were isolated, respectively, as white solid (mp=57-59° after recrystallization from diethyl ether/hexane) and uncoulorless oil.
44. H. Ent, H. De Koning and W. N. Speckamp, Heterocycles, 30, 501 (1990).